NASDAQ:ANIX

Anixa Biosciences Stock Insider Trading

Healthcare > Biotechnology

Buy ANIX

*Your capital is at risk

$3.42

-0.140 (-3.93%)

At Close: Jul 31, 2026

Anixa Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 87.82. In total, the insiders bought 4.73M and sold 174.87K ANIX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	87.82
● Buy	4.73M shares
● Sell	174.87K shares
98% Buy Activity Negligible or No Correlation
Buy Signal High Confidence Jul 20, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 87.82. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (98% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 15, 2025 Buy	Common Stock P-Purchase	Kumar Amit Chief Executive Officer	CEO / President	43 000 Value: $95.9K
Jan 02, 2025 Buy	Employee Stock Option A-Award	Titterton Lewis H Jr Director	Director	25 000 Value: $59.3K
Jan 02, 2025 Buy	Employee Stock Option A-Award	Gottschalk Emily Director	Director	25 000 Value: $59.3K
Jan 02, 2025 Buy	Employee Stock Option A-Award	Kumar Amit Chief Executive Officer	CEO / President	700 000 Value: $1.66M
Jan 02, 2025 Buy	Employee Stock Option A-Award	Baskies Arnold M Director	Director	25 000 Value: $59.3K
Jan 02, 2025 Buy	Employee Stock Option A-Award	Catelani Michael President, COO & CFO	CEO / President	350 000 Value: $829.5K
Jan 02, 2025 Buy	Employee Stock Option A-Award	Catelani Michael President, COO & CFO	CEO / President	350 000 Value: $829.5K
Jan 02, 2025 Buy	Employee Stock Option A-Award	Baskies Arnold M Director	Director	25 000 Value: $59.3K
Jan 02, 2025 Buy	Employee Stock Option A-Award	Kumar Amit Chief Executive Officer	CEO / President	700 000 Value: $1.66M
Jan 02, 2025 Buy	Employee Stock Option A-Award	Gottschalk Emily Director	Director	25 000 Value: $59.3K
Jan 02, 2025 Buy	Employee Stock Option A-Award	Titterton Lewis H Jr Director	Director	25 000 Value: $59.3K
Oct 22, 2024 Buy	Common Stock M-Exempt	Titterton Lewis H Jr Director	Director	16 000 Value: $41.2K
Oct 22, 2024 Buy	Employee Stock Option M-Exempt	Titterton Lewis H Jr Director	Director	16 000 Value: $41.2K
Oct 22, 2024 Buy	Employee Stock Option M-Exempt	Titterton Lewis H Jr Director	Director	16 000 Value: $41.2K
Oct 22, 2024 Buy	Common Stock M-Exempt	Titterton Lewis H Jr Director	Director	16 000 Value: $41.2K
Jul 31, 2024 Buy	Common Stock P-Purchase	Titterton Lewis H Jr Director	Director	5 580 Value: $18.0K
Jul 31, 2024 Buy	Common Stock P-Purchase	Titterton Lewis H Jr Director	Director	5 580 Value: $18.0K
Jul 30, 2024 Buy	Common Stock P-Purchase	Titterton Lewis H Jr Director	Director	21 646 Value: $66.2K
Jul 30, 2024 Buy	Common Stock P-Purchase	Titterton Lewis H Jr Director	Director	21 646 Value: $66.2K
Jul 26, 2024 Buy	Common Stock P-Purchase	Titterton Lewis H Jr Director	Director	7 700 Value: $23.3K
Jul 26, 2024 Buy	Common Stock P-Purchase	Titterton Lewis H Jr Director	Director	7 700 Value: $23.3K
Jul 26, 2024 Buy	Common Stock P-Purchase	Baskies Arnold M Director	Director	5 000 Value: $15.5K
Jul 26, 2024 Buy	Common Stock P-Purchase	Baskies Arnold M Director	Director	5 000 Value: $15.5K
Jul 25, 2024 Buy	Common Stock P-Purchase	Titterton Lewis H Jr Director	Director	796 Value: $2K
Jul 25, 2024 Buy	Common Stock P-Purchase	Titterton Lewis H Jr Director	Director	796 Value: $2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ANIXA BIOSCIENCES INC.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the t...

Read Full Profile Here